What is Apex AI (APEX)?
Apex AI is an artificial intelligence-driven healthcare startup focused on revolutionizing early detection and predictive diagnostics for gastrointestinal cancers, specifically stomach and colorectal cancer. Apex AI leverages advanced machine learning algorithms and extensive datasets comprising over 1 million endoscopic images to significantly enhance diagnostic accuracy, achieving 95%+ accuracy for stomach cancer and 98%+ for colorectal cancer.
How does Apex AI work?
The platform provides real-time AI-powered endoscopic analysis, continuous disease monitoring, and precise risk assessment, helping clinicians identify early-stage cancers and precancerous lesions effectively. Apex AI aims to bridge the existing diagnostic gap caused by human error, asymptomatic disease progression, and limited early-stage detection capabilities, ultimately improving patient survival rates and clinical outcomes worldwide.
Where can you buy Apex AI?
Apex AI (APEX) is traded on a wide range of centralized and decentralized exchanges. The most liquid markets for APEX sit on tier-1 venues - the sort of exchanges where institutional desks and professional market makers rebalance continuously - which is what keeps the spread tight and the last price tied closely to fair value.
You can open the Markets section above to see the live list of exchanges quoting APEX, sorted by 24-hour volume. Each row links to the venue's trade page so you can go directly from research to execution without copying the ticker around by hand.
What is the daily trading volume of Apex AI (APEX)?
The reported 24-hour trading volume of Apex AI is $446.36. Volume is a live reading of how much APEX changed hands across all tracked exchanges in the past day and tends to rise during periods of price discovery and fall during consolidation.
For traders, the ratio between volume and market cap is often more informative than either number on its own: a high vol-to-mcap ratio indicates liquid, actively traded supply, while a low ratio suggests that most holders are sitting on the asset.
